Home

KCK LTD.

CIK 1657662 · last filed 2025-02-20

KCK LTD. is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider sold $49.5M of NPCE on Feb 20, 2025. Across all open-market trades the lifetime net is −$48.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $38.2M across reported positions. The firm reports its address in Hamilton.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$38.23M

Companies

3

Total Filings

14

Lifetime Open-Market Net

-$48.67M

Filer Profile

Reported Address
CORNER HOUSE 4TH FLOOR
20 PARLIAMENT STREET
HAMILTON HM12
Phone
(441) 703-1061
State of Incorporation
Virgin Islands, British
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NPCE 10%+ Owner 0 $13.87 $0 -$51.67M 9 2025-02-20
SGHT 10%+ Owner 4,776,232 $8.01 $38.23M $0 1 2021-07-20
Rein Therapeutics, Inc. (ALRN) Delisted 10%+ Owner 22,341 $2.11 $47.1K $3.00M 1 2017-07-05

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-02-20 NPCE Sell (S) −5,270,845 -$49.55M EDGAR
2024-10-28 NPCE Sell (S) −224,138 -$1.22M EDGAR
2024-10-28 NPCE Notice (144) −223,991 -$1.22M EDGAR
2024-10-24 NPCE Sell (S) −4,082 -$24.9K EDGAR
2024-10-22 NPCE Sell (S) −8,598 -$53.4K EDGAR
2024-10-18 NPCE Sell (S) −46,426 -$303.4K EDGAR
2024-10-03 NPCE Sell (S) −39,684 -$274.7K EDGAR
2024-10-03 NPCE Notice (144) −190,000 -$1.47M EDGAR
2023-12-01 NPCE Sell (S) −16,167 -$141.9K EDGAR
2023-11-29 NPCE Sell (S) −11,171 -$99.1K EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.